Angelique Onorati

1 Title: Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma

Kim, Ravi, P. Gimotty, 2019 .

Upregulation of PD-L1 in Senescence and Aging

P. Adams, B. Lin, J. Rajagopal, 2022, Molecular and cellular biology.

Upregulation of PD-L1 in Senescence and Aging

P. Adams, B. Lin, J. Rajagopal, 2022, Molecular and cellular biology.

Nuclear autophagy interactome unveils WSTF as a constitutive nuclear inhibitor of inflammation

R. Kingston, Shannan J. Ho Sui, R. Sadreyev, 2022, bioRxiv.

ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma.

K. Flaherty, Dennie T. Frederick, M. Herlyn, 2019, Cancer discovery.

Targeting autophagy in cancer

R. Amaravadi, R. Ojha, Ravi K Amaravadi, 2018, Cancer.

Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma

P. Gimotty, Sabah Kadri, L. Appleman, 2019, Clinical Cancer Research.